DM2 Shorter telomere length tied to CV risk in diabetes A study in Diabetes Care found that relative leukocyte telomere length was significantly shorter among patients with cardiovascular disease and type 2 diabetes, compared with diabetes patients who had no CVD at baseline or did not develop CVD after mean follow-up of 13.4 years. The researchers, who based the findings on data from 5,349 diabetes patients from China, wrote that considering telomere length along with other traditional risk factors may result in improved CV risk prediction in type 2 diabetes

Shorter telomere length tied to CV risk in diabetes

A study in Diabetes Care found that relative leukocyte telomere length was significantly shorter among patients with cardiovascular disease and type 2 diabetes, compared with diabetes patients who had no CVD at baseline or did not develop CVD after mean follow-up of 13.4 years. The researchers, who based the findings on data from 5,349 diabetes patients from China, wrote that considering telomere length along with other traditional risk factors may result in improved CV risk prediction in type 2 diabetes